Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and taxifolin

2-chloro-n(6)cyclopentyladenosine has been researched along with taxifolin in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(taxifolin)
Trials
(taxifolin)
Recent Studies (post-2010) (taxifolin)
25204333019
2520435104331

Protein Interaction Comparison

ProteinTaxonomy2-chloro-n(6)cyclopentyladenosine (IC50)taxifolin (IC50)
Glycogen phosphorylase, muscle formOryctolagus cuniculus (rabbit)4.8
Pyruvate kinase PKMHomo sapiens (human)1.16
Macrophage metalloelastaseHomo sapiens (human)5.75
large T antigenBetapolyomavirus macacae31.96

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beck, S; Benzie, AL; Muellers, SN; Parkin, DW; Stockman, BJ1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and taxifolin

ArticleYear
Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.
    Bioorganic & medicinal chemistry letters, 2015, Nov-15, Volume: 25, Issue:22

    Topics: Adenosine; Antitrichomonal Agents; Flavonoids; High-Throughput Screening Assays; N-Glycosyl Hydrolases; Quercetin; Small Molecule Libraries; Stereoisomerism; Trichomonas vaginalis

2015